Osmotica Pharmaceuticals (OSMT) News Today → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free OSMT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 6, 2024 | wsj.comVanda Pharmaceuticals Inc.December 19, 2023 | investing.comRVL Pharmaceuticals PLC (RVLPQ)August 14, 2023 | markets.businessinsider.comOsmotica Pharmaceuticals is about to announce its earnings — here's what to expectMarch 19, 2023 | markets.businessinsider.comWhat Wall Street expects from Osmotica Pharmaceuticals's earningsJanuary 20, 2022 | marketbeat.comZacks Investment Research Upgrades Osmotica Pharmaceuticals (NASDAQ:OSMT) to "Hold"Zacks Investment Research upgraded shares of Osmotica Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Thursday.January 19, 2022 | nz.finance.yahoo.comGRO Biosciences Appoints Rakhshita Dhar to its Board of DirectorsJanuary 19, 2022 | finance.yahoo.comUPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceJanuary 19, 2022 | benzinga.comOsmotica Pharmaceuticals Announces Corporate Name Change to RVL Pharmaceuticals plc With New Ticker Symbol 'RVLP'January 19, 2022 | finance.yahoo.comOsmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceJanuary 18, 2022 | finance.yahoo.comRVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022January 6, 2022 | finance.yahoo.comOsmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022December 23, 2021 | marketbeat.comOsmotica Pharmaceuticals (NASDAQ:OSMT) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright assumed coverage on shares of Osmotica Pharmaceuticals in a research report on Thursday. They set a "buy" rating for the company.December 22, 2021 | nasdaq.comJames Schaub Is The Executive VP & COO of Osmotica Pharmaceuticals plc (NASDAQ:OSMT) And They Just Picked Up 30% More SharesDecember 20, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceDecember 9, 2021 | marketbeat.comOsmotica Pharmaceuticals (NASDAQ:OSMT) Lowered to "Sell" at Zacks Investment ResearchZacks Investment Research cut shares of Osmotica Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Thursday.November 17, 2021 | seekingalpha.comOsmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2021 Results - Earnings Call TranscriptNovember 17, 2021 | finance.yahoo.comOsmotica Pharmaceuticals (NASDAQ:OSMT shareholders incur further losses as stock declines 13% this week, taking three-year losses to 78%November 16, 2021 | finance.yahoo.comOsmotica Pharmaceuticals (OSMT) Reports Q3 Loss, Misses Revenue EstimatesNovember 15, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business UpdateNovember 15, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021November 14, 2021 | markets.businessinsider.comOsmotica Pharmaceuticals earnings: here's what Wall Street expectsNovember 11, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021November 2, 2021 | finance.yahoo.comAnalysts Estimate Osmotica Pharmaceuticals (OSMT) to Report a Decline in Earnings: What to Look Out forOctober 13, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingOctober 7, 2021 | msn.comBRIEF-Osmotica Pharmaceuticals PLC Announces Debt Financing From Athyrium Capital Management Of Up To $100 MlnOctober 7, 2021 | marketwatch.comOsmotica Pharma Shares Drop 37% After Note Purchase AgreementOctober 7, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc Announces Proposed Underwritten Public OfferingOctober 7, 2021 | finance.yahoo.comOsmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingOctober 7, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionOctober 4, 2021 | benzinga.comOsmotica Pharmaceuticals's Return On Capital Employed InsightsSeptember 30, 2021 | nasdaq.comDoes Osmotica Pharmaceuticals (NASDAQ:OSMT) Have A Healthy Balance Sheet?September 22, 2021 | feeds.benzinga.comOsmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021September 13, 2021 | finance.yahoo.comLoss-Making Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Expected To Breakeven In The Medium-TermSeptember 2, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceAugust 30, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc Closes Sale of Legacy Business to Alora Pharmaceuticals, LLCAugust 17, 2021 | marketwatch.comOsmotica Pharmaceuticals Shares Drop 17% After 2Q LossAugust 16, 2021 | benzinga.comOsmotica Pharmaceuticals plc Reports Second Quarter 2021 Results and Provides Business UpdateAugust 13, 2021 | au.finance.yahoo.comGovernment ‘orders 35m Pfizer vaccines for 2022 booster campaign’August 12, 2021 | apnews.comOsmotica Pharmaceuticals plc to Provide Second Quarter 2021 Business and Financial Update on ...August 12, 2021 | apnews.comOsmotica Pharmaceuticals plc to Present at H.C. Wainwright Ophthalmology Virtual Conference on ...August 12, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc to Provide Second Quarter 2021 Business and Financial Update on August 16, 2021August 12, 2021 | finance.yahoo.comOsmotica Pharmaceuticals plc to Present at H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021 Get Osmotica Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for OSMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden FINISHED On June 13th? (Ad)Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered. Click here now to see his shocking evidence. OSMT Media Mentions By Week OSMT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OSMT News Sentiment▼0.000.57▲Average Medical News Sentiment OSMT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OSMT Articles This Week▼00▲OSMT Articles Average Week Get Osmotica Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for OSMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SCYX News LABP News ASMB News LTRN News DERM News VHAQ News YS News RLYB News IFRX News MNOV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OSMT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Osmotica Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
